Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion

Technology appraisal guidance
Reference number: TA229
Published: 27 July 2011

Macular oedema (retinal vein occlusion) - dexamethasone: Appendix B - proposal paper presented to the Institutes Guidance Executive

Macular oedema (retinal vein occlusion) - dexamethasone: Appendix B - proposal paper presented to the Institutes Guidance Executive

Macular oedema (retinal vein occlusion) - dexamethasone: Appendix B - proposal paper presented to the Institutes Guidance Executive
17 November 2014
(295.09 Kb 25 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 17 November 2014